Now live: Pro — the full 13F research suite for serious investorsSee pricing →
JW Asset Management, LLC

Q2 2024 · 13F-HR

JW Asset Management, LLCholdings as filed

Filed 2024-08-08 · accession 0001019056-24-000229

$242.7M
Reported value
13
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G31249108ESTAESTABLISHMENT LABS HLDGS INC$145.1M59.8%3,192,485CommonSOLE
67066G104NVDANVIDIA CORPORATION$34.7M14.3%281,250CommonSOLE
002896207ANFABERCROMBIE & FITCH CO$11.6M4.77%65,090CommonSOLE
670100205NVONOVO-NORDISK A S$9.7M4.01%68,200CommonSOLE
92846Q107COCOVITA COCO CO INC$8.8M3.62%315,621CommonSOLE
427746102HRTXHERON THERAPEUTICS INC$8.0M3.31%2,292,418CommonSOLE
532457108LLYELI LILLY & CO$7.7M3.17%8,500CommonSOLE
14888U101CPRXCATALYST PHARMACEUTICALS INC$6.4M2.64%413,392CommonSOLE
00768Y453MSOSADVISORSHARES TR$6.1M2.51%832,283CommonSOLE
645827205IDRIDAHO STRATEGIC RESOURCES$2.7M1.10%271,697CommonSOLE
433000106HIMSHIMS & HERS HEALTH INC$1.3M0.54%65,000CommonSOLE
04523Y105ASPNASPEN AEROGELS INC$357,7500.15%15,000CommonSOLE
42981E401HITIHIGH TIDE INC$225,7380.09%102,144CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.